Read More
Mankind Pharma Reports Q4FY26 Results; PAT Jumps 32% YoY, Revenue Crosses R...
Mankind Pharma reported Q4FY26 revenue growth of 11.8 per cent YoY to Rs 3,443 crore, while quarterl...
Articles tagged with "Mankind Pharma"
Read More
This Pharma Stock Shuts Overseas Unit; Here’s Why...
Board Approves Closure of Sri Lanka Subsidiary Citing Regulatory Changes...
Read More
240 per cent growth in net profit: This small-cap stock announced robust re...
The company achieved a sales growth of 38 per cent (CAGR) over the span of three years, while its pr...
Read More
IPO Analysis: Mankind Pharma Limited IPO...
The price band of the issue has been fixed at Rs 1026 to Rs 1080 per equity share....